Eli Lilly stock slips 2.72% in favourable trading session
Updated
Updated · MarketWatch · May 8
Eli Lilly stock slips 2.72% in favourable trading session
11 articles · Updated · MarketWatch · May 8
Shares closed at $948.45 on Friday, while the S&P 500 rose 0.84% to 7,398.93 and the Dow Jones Industrial Average edged up 0.02% to 49,609.16.
The decline marked Eli Lilly's third straight daily loss, and the stock lagged rivals including Johnson & Johnson, Pfizer and AbbVie, which posted smaller falls.
Eli Lilly ended 16.36% below its 52-week high of $1,133.95 reached on 8 January, while trading volume of 3.0 million shares was slightly below its 50-day average.
Eli Lilly is investing billions, but its valuation is sky-high. Is the stock a massive opportunity or a bubble waiting to pop?
With its new pill's sluggish start, can Eli Lilly defend its market dominance against a resurgent Novo Nordisk?